1990-2019年加拿大类风湿关节炎的全国疾病负担:2019年全球疾病负担研究的发现——一项由GBD合作者主导的研究
该研究基于全球疾病负担研究(GBD)数据,描述1990至2019年加拿大类风湿关节炎(RA)的患病率、死亡率、早死寿命损失年、伤残寿命损失年和伤残调整寿命年及其趋势,并按年龄和性别分析差异,同时与其他高社会人口指数国家比较。结果显示加拿大RA年龄标化患病率上升27%、死亡率下降27%、早死寿命损失年率下降30%、伤残寿命损失年上升27%、伤残调整寿命年率上升13%,女性所有指标负担均高于男性,伤残调整寿命年率在75-79岁年龄组达峰。
要点
- 1990至2019年加拿大RA年龄标化患病率上升27%,伤残调整寿命年率上升13%。
- 同期RA年龄标化死亡率下降27%、早死寿命损失年率下降30%,2002年后下降尤为明显。
- 女性所有负担指标均高于男性,伤残调整寿命年率在75-79岁年龄组达峰。
核心结论
- 加拿大RA负担指标随时间的变化趋势及年龄和性别差异对加拿大政策制定者、研究者和照护提供者具有重要意义。
- 作者认为,对女性RA的早期识别和管理可能有助于降低加拿大RA的总体负担。
研究设计与样本
- 基于全球疾病负担、损伤和危险因素研究(GBD)数据,描述1990至2019年加拿大RA负担及趋势、年龄和性别差异,并与其他国家比较。
- 疾病负担指标包括患病率、死亡率、早死寿命损失年(YLLs)、伤残寿命损失年(YLDs)和伤残调整寿命年(DALYs)。
- GBD使用已发表文献、调查数据和医疗保险索赔数据估算致命和非致命结局。
- 数据分析采用贝叶斯荟萃回归、死因集成模型和其他统计方法。
- 将加拿大的DALYs与具有相似高社会人口指数值的国家进行比较。
主要发现
- 1990至2019年加拿大RA年龄标化患病率上升27%,死亡率下降27%,YLL率下降30%,YLD上升27%,DALY率上升13%。
- RA死亡率和YLL率的下降在2002年后尤为明显。
- 女性所有负担指标均高于男性,DALY率在老年年龄组更高,于75-79岁年龄组达峰。
- 加拿大的患病率和DALYs高于全球水平。
临床怎么用
- 作者认为,对女性RA的早期识别和管理可能有助于降低加拿大RA的总体负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objectives of this study were: (1) to describe burden of rheumatoid arthritis (RA) and trends from 1990 to 2019 using the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) data, (2) to describe age and sex differences in RA and (3) to compare Canada's RA burden to that of other countries. METHODS: Disease burden indicators included prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs) and disability-adjusted life-years (DALYs). GBD estimated fatal and non-fatal outcomes using published literature, survey data and health insurance claims. Data were analysed by Bayesian meta-regression, cause of death ensemble model and other statistical methods. DALYs for Canada were compared with DALYs of countries with similarly high Socio-Demographic Index values. RESULTS: In Canada, the RA prevalence rate increased by 27% between 1990 and 2019, mortality rate decreased by 27%, YLL rate decreased by 30%, YLD increased by 27% and DALY rate increased by 13%, all age standardised. The decline in RA mortality and YLL rates was especially pronounced after 2002. The disease burden was higher in females for all indicators, and DALY rates were higher among older age groups, peaking at age 75-79 years. Prevalence and DALYs were higher in Canada compared with global rates. CONCLUSION: Trends in RA burden indicators over time and differences by age and sex have important implications for Canadian policy-makers, researchers and care providers. Early identification and management of RA in women may help reduce the overall burden of RA in Canada.
引用
- Hassen N, Lacaille D, Xu A, et al. National burden of rheumatoid arthritis in Canada, 1990-2019: findings from the Global Burden of Disease Study 2019 - a GBD collaborator-led study. RMD Open. 2024. PMID: 38216285. doi:10.1136/rmdopen-2023-003533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。